Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,324 | 7,427 | 86,190 | 10,645 | 31,378 |
| Marketable Securities | 163,163 | 45,950 | N/A | N/A | 6,001 |
| Receivables | N/A | N/A | N/A | 103 | 15,663 |
| Inventories | N/A | N/A | N/A | N/A | 16,274 |
| Other current assets | 0 | 0 | 0 | 0 | 55,492 |
| TOTAL | $193,416 | $55,225 | $86,445 | $10,953 | $124,808 |
| Non-Current Assets | |||||
| PPE Net | 3,033 | 1,325 | 1,362 | 759 | 525,160 |
| Other Non-Current Assets | 1,518 | 3,099 | 509 | 417 | 0 |
| TOTAL | $4,551 | $4,424 | $1,871 | $1,176 | $525,160 |
| Total Assets | $197,967 | $59,649 | $88,316 | $12,129 | $695,212 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,857 | 1,437 | 1,200 | 342 | 0 |
| Accrued Expenses | 7,575 | 4,406 | 1,913 | 657 | N/A |
| TOTAL | $12,517 | $5,921 | $3,188 | $999 | $134,043 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 85 | 78 | 75 | N/A | N/A |
| Other Non-Current Liabilities | 505 | 3,619 | 788 | 487 | 1,044 |
| TOTAL | $505 | $3,619 | $788 | $487 | $1,044 |
| Total Liabilities | $13,022 | $9,540 | $3,976 | $1,486 | $335,564 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,596 | 30,036 | N/A | N/A | N/A |
| Common Shares | 32 | 4 | 3 | 3 | N/A |
| Retained earnings | -139,041 | -74,836 | -27,058 | -8,155 | 284,082 |
| Other shareholders' equity | -174 | 124,941 | 111,387 | 18,604 | 75,566 |
| TOTAL | $184,945 | $50,109 | $84,340 | $10,643 | $359,648 |
| Total Liabilities And Equity | $197,967 | $59,649 | $88,316 | $12,129 | $695,212 |